ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 91 filers reported holding ONCOMED PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,273,000 | +41.4% | 4,108,815 | +1.6% | 0.48% | +21.0% |
| Q4 2018 | $3,021,000 | -64.8% | 4,042,989 | 0.0% | 0.40% | -47.5% |
| Q3 2018 | $8,571,000 | -9.5% | 4,042,989 | -1.4% | 0.75% | -18.5% |
| Q2 2018 | $9,470,000 | -30.0% | 4,099,589 | -3.6% | 0.92% | -32.6% |
| Q1 2018 | $13,525,000 | -22.8% | 4,253,189 | -0.4% | 1.37% | -35.1% |
| Q4 2017 | $17,512,000 | -12.0% | 4,271,289 | -2.9% | 2.11% | -16.5% |
| Q3 2017 | $19,889,000 | +35.7% | 4,400,289 | 0.0% | 2.53% | +11.1% |
| Q2 2017 | $14,653,000 | -9.6% | 4,400,289 | +149.9% | 2.28% | -17.5% |
| Q1 2017 | $16,214,000 | +19.5% | 1,760,489 | 0.0% | 2.76% | +1.1% |
| Q4 2016 | $13,573,000 | -34.5% | 1,760,489 | -2.8% | 2.73% | -30.1% |
| Q3 2016 | $20,711,000 | +25.6% | 1,812,005 | +35.3% | 3.90% | +11.1% |
| Q2 2016 | $16,487,000 | +21.8% | 1,339,336 | 0.0% | 3.51% | +4.8% |
| Q1 2016 | $13,541,000 | -39.4% | 1,339,336 | +35.1% | 3.35% | -12.0% |
| Q4 2015 | $22,347,000 | -2.1% | 991,433 | -28.0% | 3.81% | -17.4% |
| Q3 2015 | $22,830,000 | -19.8% | 1,376,113 | +8.8% | 4.61% | -8.2% |
| Q2 2015 | $28,456,000 | -14.0% | 1,264,715 | -1.5% | 5.02% | -27.4% |
| Q1 2015 | $33,104,000 | +10.7% | 1,284,115 | -6.6% | 6.92% | +19.0% |
| Q4 2014 | $29,916,000 | +22.7% | 1,374,815 | +6.8% | 5.82% | +15.0% |
| Q3 2014 | $24,379,000 | +26.7% | 1,287,847 | +56.0% | 5.06% | +66.4% |
| Q2 2014 | $19,238,000 | -42.2% | 825,647 | -16.6% | 3.04% | -41.1% |
| Q1 2014 | $33,306,000 | +3.5% | 989,778 | -9.2% | 5.16% | -8.3% |
| Q4 2013 | $32,191,000 | +436.7% | 1,090,478 | +178.3% | 5.63% | +445.7% |
| Q3 2013 | $5,998,000 | – | 391,800 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|